Skip to content
Recall Observatory FDA recall evidence

Drug product

CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96

D-237-2013

February 07, 2013

Class II

Product summary

Firm
Teva Pharmaceuticals USA, Inc.
Event
Event 64305
Status
Terminated
Classification
Class II
Quantity
3 boxes
Official record key
drug-enforcement:D-237-2013

Official wording

Reason: Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.

Code information: Lot # 32900136A, Exp. 05/14

Distribution pattern: NC

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out-of-specification